[FCN3 Can Serve as A Potential Biomarker for Prognosis and Immunotherapy of Lung Squamous Cell Carcinoma].
High expression of FCN3 in LUSC is associated with poor prognosis and is linked to immune cell infiltration, immune-related pathways, and immune-related molecules. FCN3 may be a potential prognostic marker and a new target for immunotherapy in LUSC.
Authors
- Lingling Zu (ORCID: https://orcid.org/0000-0002-6976-6579)
- Song Xu
- Wei Li (ORCID: https://orcid.org/0000-0002-9991-7892)
Institutions
- Tianjin Medical University General Hospital (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-02-20
- DOI
- https://doi.org/10.3779/j.issn.1009-3419.2025.105.01
- Citations
- 1
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article